Placeholder Banner

102 Organizations Urge Congress to Maintain a Strong Patent System and Protect Innovation

September 10, 2015
A diverse group of more than 100 national and state-based advocacy organizations have united to urge Congress to preserve important patent protections that incentivize biopharmaceutical research necessary to innovate and develop new cures and treatments for serious diseases.

In a letter sent to the Hill this week, these patient advocates asked Congress to amend the Innovation Act (H.R. 9) to preserve the highly-detailed and sophisticated systems designed by Hatch-Waxman and BPCIA and avoid weakening the patents that sustain medical research.

Similarly, a coalition of 79 house members recently submitted a letter to leaders, requesting significant improvement upon language this same bill.